Clinical Trials
3 trialsNCT01352962 2026-04-14
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02018523 2018-01-18
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Baylor College of Medicine
Phase 1 Terminated
NCT00179699 2005-11-07
Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer
Celgene
Phase 1 Terminated